Exclusive Content
Cipla Receives U.S. FDA Approval for Generic Advair Diskus®️
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., have received approval from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Application...
Government of Andhra Pradesh Partners to Launch AI and Genomic-Powered 360-Degree Oncology Care Model
The Government of Andhra Pradesh has announced a strategic partnership to implement a groundbreaking 360-degree oncology care model designed to transform early cancer detection,...
Cognizant Expands Strategic Partnership with Novartis to Transform Global IT Operations using Agentic AI
Cognizant has announced a new five-year, AI-enabled integrated IT operations agreement with Novartis, expanding a strategic relationship that spans more than two decades.
Under the...
QDENGA: A Milestone in India’s Battle Against Dengue
The onset of monsoon in India apart from bringing relief from the sweltering heat marks the rise of dengue cases. Every year, lakhs of people infected by...
Medtronic MEIC Expands Breast and Cervical Cancer Screenings in Hyderabad
The Medtronic Engineering and Innovation Center (MEIC) in Hyderabad has initiated a series of health and development initiatives aimed at uplifting underserved local communities.
Driven by Medtronic’s core mission...
Lupin Introduces Kaveri Therapeutics to Accelerate Cancer Drug Development
Lupin Limited announced the strategic spin-out of two promising oncology assets LNP7457 (PRMT5) and LNP8701 (SOS1) into Kaveri Therapeutics Inc. , a U.S.-based, clinical-stage oncology company dedicated to advancing targeted...
